1. Home
  2. CDIO vs LUXH Comparison

CDIO vs LUXH Comparison

Compare CDIO & LUXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • LUXH
  • Stock Information
  • Founded
  • CDIO 2017
  • LUXH 2017
  • Country
  • CDIO United States
  • LUXH United States
  • Employees
  • CDIO N/A
  • LUXH N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • LUXH Real Estate
  • Sector
  • CDIO Health Care
  • LUXH Finance
  • Exchange
  • CDIO Nasdaq
  • LUXH Nasdaq
  • Market Cap
  • CDIO 12.4M
  • LUXH 12.7M
  • IPO Year
  • CDIO N/A
  • LUXH N/A
  • Fundamental
  • Price
  • CDIO $0.26
  • LUXH $0.04
  • Analyst Decision
  • CDIO Buy
  • LUXH Hold
  • Analyst Count
  • CDIO 1
  • LUXH 2
  • Target Price
  • CDIO $2.00
  • LUXH N/A
  • AVG Volume (30 Days)
  • CDIO 5.4M
  • LUXH 33.9M
  • Earning Date
  • CDIO 11-13-2024
  • LUXH 11-26-2024
  • Dividend Yield
  • CDIO N/A
  • LUXH N/A
  • EPS Growth
  • CDIO N/A
  • LUXH N/A
  • EPS
  • CDIO N/A
  • LUXH N/A
  • Revenue
  • CDIO $39,138.00
  • LUXH $90,865,323.00
  • Revenue This Year
  • CDIO $2,093.61
  • LUXH N/A
  • Revenue Next Year
  • CDIO $43.05
  • LUXH $15.51
  • P/E Ratio
  • CDIO N/A
  • LUXH N/A
  • Revenue Growth
  • CDIO 1363.10
  • LUXH 14.73
  • 52 Week Low
  • CDIO $0.19
  • LUXH $0.03
  • 52 Week High
  • CDIO $3.56
  • LUXH $6.88
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 45.30
  • LUXH 39.09
  • Support Level
  • CDIO $0.21
  • LUXH $0.04
  • Resistance Level
  • CDIO $0.52
  • LUXH $0.06
  • Average True Range (ATR)
  • CDIO 0.06
  • LUXH 0.01
  • MACD
  • CDIO -0.00
  • LUXH 0.00
  • Stochastic Oscillator
  • CDIO 6.27
  • LUXH 21.67

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

About LUXH LuxUrban Hotels Inc.

LuxUrban Hotels Inc utilizes a long term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in metropolitan cities. It identifies, acquires, manages, and markets hotel rooms to business and vacation travelers under the consumer brand, LuxUrban. It manages a portfolio of hotel rooms in New York, Washington D.C., Miami Beach, New Orleans and Los Angeles.

Share on Social Networks: